<?xml version="1.0"?>
<Articles JournalTitle="Iranian Journal of Allergy, Asthma and Immunology">
  <Article>
    <Journal>
      <PublisherName>Tehran University of Medical Sciences</PublisherName>
      <JournalTitle>Iranian Journal of Allergy, Asthma and Immunology</JournalTitle>
      <Issn>1735-1502</Issn>
      <Volume>12</Volume>
      <Issue>3</Issue>
      <PubDate PubStatus="epublish">
        <Year>2013</Year>
        <Month>09</Month>
        <Day>15</Day>
      </PubDate>
    </Journal>
    <title locale="en_US">Low and High CD8 Positive T cells in Multiple Sclerosis Patients</title>
    <FirstPage>276</FirstPage>
    <LastPage>280</LastPage>
    <Language>EN</Language>
    <AuthorList>
      <Author>
        <FirstName>Maryam</FirstName>
        <LastName>Izad</LastName>
        <affiliation locale="en_US">Department of Immunology, Faculty of Medicine, Tehran University of Medical Sciences, Tehran, Iran.</affiliation>
      </Author>
      <Author>
        <FirstName>Mohammad Hossein</FirstName>
        <LastName>Harirchian</LastName>
        <affiliation locale="en_US">Iranian Neurological Research Center, Imam Khomeini Hospital, Tehran University of Medical Sciences, Tehran, Iran.</affiliation>
      </Author>
      <Author>
        <FirstName>Hamed</FirstName>
        <LastName>Amiri</LastName>
        <affiliation locale="en_US">Iranian Neurological Research Center, Imam Khomeini Hospital, Tehran University of Medical Sciences, Tehran, Iran.</affiliation>
      </Author>
      <Author>
        <FirstName>Farangis</FirstName>
        <LastName>Najafi</LastName>
        <affiliation locale="en_US">Department of Immunology, Faculty of Medicine, Tehran University of Medical Sciences, Tehran, Iran.</affiliation>
      </Author>
      <Author>
        <FirstName>Zahra</FirstName>
        <LastName>Ghaflati</LastName>
        <affiliation locale="en_US">Department of Immunology, Faculty of Medicine, Tehran University of Medical Sciences, Tehran, Iran.</affiliation>
      </Author>
      <Author>
        <FirstName>Zahra</FirstName>
        <LastName>Salehi</LastName>
        <affiliation locale="en_US">Department of Immunology, Faculty of Medicine, Tehran University of Medical Sciences, Tehran, Iran.</affiliation>
      </Author>
    </AuthorList>
    <History>
      <PubDate PubStatus="received">
        <Year>2015</Year>
        <Month>10</Month>
        <Day>16</Day>
      </PubDate>
    </History>
    <abstract locale="en_US">Cumulating evidence points to a key role for CD8+ T cells in the pathogenesis of multiple sclerosis.CD8 expression level was believed to be present constantly on the surface of human peripheral blood T cells. However, it was shown that peripheral blood lymphocytes may be divided by the level of CD8 expression, into CD8+high and CD8+low T cells. Now it is well established that the CD8low population of CD8+ T cells demonstrates an activated effector phenotype while the CD8+high T cells have been reported to have regulatory function. In this report we used a flow cytometric assay to compare the frequency of these two subsets in multiple sclerosis patients (n=31) with healthy age- and gender-matched controls (n=18). We found that CD8+ T cells and CD8+low T cells significantly increased in secondary progressive (SP) and primary progressive multiple sclerosis (PPMS) patients in comparison to controls (p&lt;0.0002 and p&lt;0.004 respectively) and also RRMS (p&lt;0.005 and p&lt;0.017 respectively). These results demonstrated the role of CD8low T cells in progressive form of multiple sclerosis.</abstract>
    <web_url>https://ijaai.tums.ac.ir/index.php/ijaai/article/view/502</web_url>
    <pdf_url>https://ijaai.tums.ac.ir/index.php/ijaai/article/download/502/538</pdf_url>
  </Article>
</Articles>
